StockData
Pulmatrix, Inc. logo

Pulmatrix, Inc. (PULM) stock

PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.37+0.04 (+3.01%)

Close on Nov 17, 2026Market cap $5.00MP/E –Yield –

Pulmatrix total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Pulmatrix's total debt was $0 at Dec 31, 2018. For fiscal 2018 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2018Dec 31, 2018$0-100.0%
FY2017Dec 31, 2017$3.22M-44.5%
FY2016Dec 31, 2016$5.80M-13.7%
FY2015Dec 31, 2015$6.72M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2018Dec 31, 2018$0-100.0%
Q1 FY2018Mar 31, 2018$2.52M-51.3%
Q4 FY2017Dec 31, 2017$3.22M-44.5%
Q3 FY2017Sep 30, 2017$3.90M–
Q2 FY2017Jun 30, 2017$4.55M–
Q1 FY2017Mar 31, 2017$5.18M–
Q4 FY2016Dec 31, 2016$5.80M–

More Pulmatrix figures

See a number that looks wrong?